185 related articles for article (PubMed ID: 872468)
1. Immunological response in patients receiving Corynebacterium parvum therapy.
Osborn DE; Castro JE
Clin Oncol; 1977 Jun; 3(2):155-64. PubMed ID: 872468
[No Abstract] [Full Text] [Related]
2. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.
Webster DJ; Chare MJ; Baum M
Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540
[TBL] [Abstract][Full Text] [Related]
3. The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients.
James K; Clunie GJ; Woodruff MF; McBride WH; Stimson WH; Drew R; Catty D
Br J Cancer; 1975 Sep; 32(3):310-22. PubMed ID: 61040
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary considerations on the intravenous use of Corynebacterium parvum in the treatment of solid neoplasms].
Scheinberg MA; Sartori JP; de Pinho JG
AMB Rev Assoc Med Bras; 1979 Apr; 25(4):139-40. PubMed ID: 315598
[No Abstract] [Full Text] [Related]
5. Lung cancer patients treated with Corynebacterium parvum. Phase I toxicity study.
Yadeau R; Bates HA; Fortuny I
Minn Med; 1979 Sep; 62(9):673-5. PubMed ID: 503003
[No Abstract] [Full Text] [Related]
6. Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: a preliminary report of clinical and biologic findings.
Israël L; Edelstein R; Depierre A; Dimitrov N
J Natl Cancer Inst; 1975 Jul; 55(1):29-33. PubMed ID: 1080521
[TBL] [Abstract][Full Text] [Related]
7. Immunochemotherapy with Corynebacterium parvum in disseminated cancer.
Israel L
Ann N Y Acad Sci; 1976; 277(00):241-51. PubMed ID: 187100
[No Abstract] [Full Text] [Related]
8. [Treatment of malignant tumors with spores of Clostridium butyricum M 55. 3. Therapeutic experiments on metastasizing tumors of various organs].
Kretschmer H; Gläser A; Grässer A
Arch Geschwulstforsch; 1972; 39(4):315-21. PubMed ID: 4560621
[No Abstract] [Full Text] [Related]
9. Immunotherapy of patients with cancer.
Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
[No Abstract] [Full Text] [Related]
10. Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.
Noonan FP; Halliday WJ; Wall DR; Clunie GJ
Cancer Res; 1977 Aug; 37(8 Pt 1):2473-80. PubMed ID: 872076
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of two nonspecific immune stimuli in antiblastic chemotherapy].
Bianucci P; Pastorino G
Arch Sci Med (Torino); 1980; 137(1):33-40. PubMed ID: 7458652
[TBL] [Abstract][Full Text] [Related]
12. Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma.
Karakousis CP; Didolkar MS; Han T
Cancer Treat Rep; 1981; 65(9-10):925-6. PubMed ID: 7273032
[No Abstract] [Full Text] [Related]
13. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
14. Local Corynebacterium parvum therapy in early breast cancer: a pilot study.
Boak JL
Clin Oncol; 1978 Sep; 4(3):235-42. PubMed ID: 750126
[No Abstract] [Full Text] [Related]
15. Corynebacterium parvum antibodies in healthy and cancer patients.
Hardas U; Jalgaonkar SV; Chatterjee AK
Indian J Cancer; 1982; 19(2):113-5. PubMed ID: 7129515
[No Abstract] [Full Text] [Related]
16. Clinical studies with Corynebacterium parvum.
Mitcheson HD; Castro JE
Dev Biol Stand; 1977 Apr 13-15; 38():509-14. PubMed ID: 344105
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of anamnestic humoral responses by a single intravenous injection of Corynebacterium parvum (C. parvum) in adult rabbits.
Parlebas J; Halpern B
Dev Biol Stand; 1977 Apr 13-15; 38():201-4. PubMed ID: 608507
[No Abstract] [Full Text] [Related]
18. A comparison of the toxicity of two formulations of Corynebacterium parvum in a double-blind crossover trial in patients with bronchogenic carcinoma.
Mitcheson HD; Priestman TJ
Clin Oncol; 1981 Sep; 7(3):179-82. PubMed ID: 7044635
[No Abstract] [Full Text] [Related]
19. Combined use of local irradiation and Corynebacterium parvum in the treatment of the murine line 1 lung carcinoma.
Ullrich RL; Adams LM
Radiat Res; 1978 Feb; 73(2):267-73. PubMed ID: 204955
[No Abstract] [Full Text] [Related]
20. [5 years' experience in the immunotherapy of human cancer].
Humphrey LJ; Boehm OR; Boehm BJ; Jewell WR
Zentralbl Chir; 1973 Sep; 98(35):1241-6. PubMed ID: 4784998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
